Dodecane

Dodecane

SCHEMBL29645029

CCCCCCCCCCCC.O=[N+]([O-])O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Dodecane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
CES2 O00748 4/20 0.52
CES1 P23141 4/20 0.52
TSHR P16473 5/20 0.50
THRB P10828 1/20 0.50
CA5A P35218 1/20 0.50
CA5B Q9Y2D0 1/20 0.50
LMNA P02545 2/20 0.45
HSD17B10 Q99714 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PPARG P37231 4/20 0.43
PPARD Q03181 4/20 0.43
PPARA Q07869 4/20 0.43
GPR84 Q9NQS5 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
TLR2 O60603 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL27389558 1.00 ALDH1A1 (0.62) ALDH1A1CES2CES1TSHRTHRB
Heptane SCHEMBL27401561 1.00 ALDH1A1 (0.62) ALDH1A1CES2CES1TSHRTHRB
Decane SCHEMBL15053043 1.00 ALDH1A1 (0.62) ALDH1A1CES2CES1TSHRTHRB
Nonane SCHEMBL27883833 1.00 ALDH1A1 (0.62) ALDH1A1CES2CES1TSHRTHRB
Hexadecane SCHEMBL380459 1.00 ALDH1A1 (0.62) ALDH1A1CES2CES1TSHRTHRB
Octane SCHEMBL8954452 1.00 ALDH1A1 (0.62) ALDH1A1CES2CES1TSHRTHRB
Octane SCHEMBL9793297 1.00 ALDH1A1 (0.62) ALDH1A1CES2CES1TSHRTHRB
Nitric Acid SCHEMBL27586906 0.97 ALDH1A1 (0.59) ALDH1A1CES2CES1TSHRTHRB
Heptane SCHEMBL27357041 0.97 ALDH1A1 (0.59) ALDH1A1CES2CES1TSHRTHRB
Hexane SCHEMBL27687689 0.97 ALDH1A1 (0.57) ALDH1A1CES2CES1TSHRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12319654-B2 Inert nanocapsules THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) 2025-06-03 US disclosed
US-20220177431-A1 INERT NANOCAPSULES THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12319654-B2 Inert nanocapsules CHRM2, CHRM5, NCL ALDH1A1 4254/4885CES2 1957/4885CES1 4328/4885
US-20220177431-A1 INERT NANOCAPSULES CHRM2, CHRM5, CLN6 ALDH1A1 4216/4885CES2 1894/4885CES1 4287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.